Azure Healthcare’s (ASX:AZV) subsidiary wins $1.6M contract

" Azure Healthcare’s (ASX:AZV) subsidiary wins $1.6M contract

Azure Healthcare’s (AZV) subsidiary, Austco Canada, has received $1.6 million contract to supply its Tacera Nurse Call platform to a new 350 be…
Recce Pharmaceuticals (ASX:RCE) - CEO, James Graham - The Market Herald

" Recce Pharmaceuticals’ (ASX:RCE) anti-infectives receive Japanese patent

Recce Pharmaceuticals (RCE) has received a Japanese patent for its synthetic anti-infectives Recce 327 (R327) and Recce 529 (R529).
Incannex Healthcare (ASX:IHL) - Chief Medical Officer, Dr Sud Agarwal (centre) - The Market Herald

" Incannex Healthcare (ASX:IHL) looks to fast-track treatment registration

Animal studies testing Incannex Healthcare’s (IHL) IHL-675A combination therapy have shown a response even better than predicted.
Imagion Biosystems (ASX:IBX) - Executive Chairman, Bob Proulx - The Market Herald

" Imagion Biosystems (ASX:IBX) completes $6M placement

Imagion Biosystems (IBX) has successfully completed a placement and raised $6 million.
Cann Group (ASX:CAN) - CEO, Peter Crock - The Market Herald

" Cann Group (ASX:CAN) secures $50M loan for Mildura

Cann Group (CAN) has secured a $50 million loan from National Australia Bank (NAB).
Medibio (ASX:MEB) - Senior Vice President of Corporate Health, Jennifer Solitario - The Market Herald

" Medibio (ASX:MEB) teams up with Compass for corporate wellness product

Medibio (MEB) has signed a three-year global master licence and services agreement with Compass Group for Medibio’s mental health product, ilumen.
Imugene (ASX:IMU) - CEO, Leslie Chong - The Market Herald

" Imugene’s (ASX:IMU) shares rise 20pc on positive HER-Vaxx results

Imugene (IMU) has unveiled some positive data from its ongoing phase two study of HER-Vaxx in advanced gastric cancer.
Vectus Biosystems (ASX:VBS) fast-tracks clinical trials with $7M financing

" Vectus Biosystems (ASX:VBS) fast-tracks clinical trials with $7M financing

Vectus Biosystems (VBS) has received firm commitments from institutional and sophisticated investors to raise a total of $7 million.
Regis Healthcare (ASX:REG) - Managing Director and CEO, Linda Mellors - The Market Herald

" Regis Healthcare (ASX:REG) shoots down second Soul Patts takeover bid in two months

Regis Healthcare (REG) has shot down a $555 million takeover bid from investment giant Washington H. Soul Pattinson (SOL) and major shareholder Ashburn.
NeuroScientific Biopharmaceuticals (ASX:NSB) - Managing Director & CEO, Matthew Liddelow - The Market Herald

" NeuroScientific Biopharmaceuticals (ASX:NSB) launches post-COVID fibrosis research program

NeuroScientific Biopharmaceuticals (NSB) is teaming up with the Institute of Respiratory Health and the University of Western Australia to find a treatment for